BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34257675)

  • 1. Effect of Omega-3 Fatty Acid Alone and in Combination with Proprietary Chromium Complex on Endothelial Function in Subjects with Metabolic Syndrome: A Randomized, Double-Blind, Parallel-Group Clinical Study.
    Pingali U; Nutalapati C; Gundagani S
    Evid Based Complement Alternat Med; 2021; 2021():2972610. PubMed ID: 34257675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus - A Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Pingali U; Nutalapati C; Illendulla VS
    Diabetes Metab Syndr Obes; 2020; 13():31-42. PubMed ID: 32021349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
    Usharani P; Merugu PL; Nutalapati C
    BMC Complement Altern Med; 2019 May; 19(1):97. PubMed ID: 31060549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial.
    Signori C; DuBrock C; Richie JP; Prokopczyk B; Demers LM; Hamilton C; Hartman TJ; Liao J; El-Bayoumy K; Manni A
    Eur J Clin Nutr; 2012 Aug; 66(8):878-84. PubMed ID: 22669332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
    Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
    Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Resistance Modifies the Effects of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction (from the OMEGA-REMODEL Randomized Clinical Trial).
    Fujikura K; Heydari B; Ge Y; Kaneko K; Abdullah S; Harris WS; Jerosch-Herold M; Kwong RY
    Am J Cardiol; 2020 Mar; 125(5):678-684. PubMed ID: 31948661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
    Kwong RY; Heydari B; Ge Y; Abdullah S; Fujikura K; Kaneko K; Harris WS; Jerosch-Herold M; Antman EM; Seidman JG; Pfeffer MA
    PLoS One; 2019; 14(9):e0222061. PubMed ID: 31532795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
    Atkin M; Laight D; Cummings MH
    J Diabetes Complications; 2016; 30(4):723-7. PubMed ID: 26954484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study on omega-3 fatty acids in type I diabetes mellitus.
    Landgraf-Leurs MM; Drummer C; Fröschl H; Steinhuber R; Von Schacky C; Landgraf R
    Diabetes; 1990 Mar; 39(3):369-75. PubMed ID: 2137803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.
    Xu F; Fan W; Wang W; Tang W; Yang F; Zhang Y; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2019 Apr; 236(4):1273-1279. PubMed ID: 30519766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Response to Omega-3 Fatty Acids and Vitamin E Co-Supplementation in Patients with Fibrocystic Breast Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirhashemi SM; Sahmani M; Salehi B; Zavar Reza J; Taghizadeh M; Moussavi N; Badehnoosh B; Asemi Z
    Arch Iran Med; 2017 Aug; 20(8):466-473. PubMed ID: 28846009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
    J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastain combined with omega-3 fatty acids on high sensitive C-reactive protein, lipidemia, and fibrinolysis in patients with mixed dyslipidemia.
    Hong H; Xu ZM; Pang BS; Cui L; Wei Y; Guo WJ; Mao YL; Yang XC
    Chin Med Sci J; 2004 Jun; 19(2):145-9. PubMed ID: 15250255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
    Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS
    Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study.
    Ansquer JC; Bekaert I; Guy M; Hanefeld M; Simon A;
    Am J Cardiovasc Drugs; 2009; 9(2):91-101. PubMed ID: 19331437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.